key: cord-0911172-0th62u0i
authors: Mahmood, Tariq; Singh, Niraj Kumar; Singh, Atul Kumar
title: Analysis of clinical sign and symptoms and biochemical parameters of post-COVID patients
date: 2022-02-28
journal: Lung India
DOI: 10.4103/lungindia.lungindia_165_21
sha: 62698ea4b399a62b7419f2ac9bf62311f127ba1d
doc_id: 911172
cord_uid: 0th62u0i

nan

in which 100 post-COVID patients were included. We retrospectively analyzed and evaluated the epidemiological history, comorbidities, vital signs and symptoms and blood parameters such as CBC, kidney function test, liver function test, S. electrolytes, RBS, ESR, CRP, glycated hemoglobin, D-Dimer, S. LDH, S. ferritin, S. procalcitonin, and PT-INR. Different variables were expressed as percentages. Demographic data and COVID-19 course of involved participants are expressed in Table 1 . Post-COVID manifestations are expressed in Table 2 .

In 100 post-COVID patients, 33 were women and 77 were men. Of these patients, 60 had one or more comorbidities. Diabetes (60%) and hypertension (35%) were most common coexisting conditions. CKD found in 9% of cases, asthma in 21% of cases, and COPD found in 27% of cases. The severity of post-COVID patients was divided into three categories, mild group of 27% patients had breathlessness on exertion requiring intermittent moist oxygen support with face mask or nasal prongs, moderate group of 63% patients had breathlessness at rest and required high flow oxygen devices, severe group of 10% patients were on bipap support. In our study, 88% of patients complaint about marked weakness, 30% had lethargy, and 47% showed sleeplessness and forgetfulness found in 20% of patients.

In blood parameters, we found that 87% patients had increased D-Dimer, 65% had increased S. ferritin, and 83% had markedly raised S. LDH levels. Seventy-one Sir,

In late December 2019, a large number of patients were admitted to the hospital with an initial diagnosis of pneumonia of unknown etiology in Wuhan-China. [1] Early reports predicted the onset of this pneumonia as a potential coronavirus outbreak. [2] Coronavirus primarily targets the human respiratory system. Novel coronavirus-induced pneumonia which was named as coronavirus disease-2019 (COVID-19) by the WHO on February 11, 2020, has rapidly increased in the epidemic scale. [3] On the same day, the international virus classification commission announced the novel coronavirus as SARS-COV 2. Rapid spread of COVID-19 progress and lack of specific therapeutic measures resulted in an epidemic. On January 31, 2020, the WHO announced that COVID-19 was listed as the public health emergency of international concern.

The symptom of COVID-19 infection appears after an incubation period of approximately 4-14 days. [4] The most common symptoms of COVID-19 disease include fever, cough, and breathlessness while other symptoms are headache, hemoptysis, diarrhea, and fatigue. [5] Several comorbidities affect pathogenesis such as cellular immune deficiency, coagulation activation, myocardial injury, hepatic and kidney injury, lymphopenia, and secondary bacterial infections leading to severe disease and death. [6] COVID-19 patients showed different blood biochemical characteristics that may be associated with disease severity and progress. Different studies showed, patients of COVID-19 had lymphopenia, raised lactate dehydrogenase (LDH), raised C-reactive protein (CRP), raised serum ferritin, and higher levels of D-Dimer. [7] Increased level of alanine transaminase, aspartate transaminase and bilirubin indicates significant liver dysfunction. [8] Severe inflammation was indicated by raised erythrocyte sedimentation rate (ESR), interleukin-6, and CRP levels. [9] Raised Procalcitonin suggested the possibilities of multiple infections. [10] Hypokalemia was evident due to continuous k+ loss resulting from degradation of ACE2. [11] Kidney injury was suggested by raised levels of S. urea and creatinine that is related with high expression of ACE2 in glomerular cells. [12] Several studies showed linear relationship between raised serum LDH level and the severity of the disease. [13] Coagulopathy and overt DIC appears to be associated with high mortality rate where D-Dimer elevation >1 μg/L was strongest independent predictor of mortality. [14] Among hematogenous parameters lymphopenia is clearly associated with disease severity. [15] We conducted a study in Department of Pulmonary Medicine MLN Medical College Allahabad, Prayagraj Analysis of clinical sign and symptoms and biochemical parameters of post-COVID patients We concluded that diabetes was the most common comorbid condition in post-COVID patients and weakness was the most prevailing symptom apart from the characteristics symptoms of COVID-19 such as fever, cough, and breathlessness. Maximum number of patients had raised level of CRP, ESR, S. LDH, S. Ferritin, D-Dimer, and S. Procalcitonin levels, with close monitoring of these parameters the disease progress and severity may be closely observed and possibly prevented. These parameters may also be prognostic indicators.

Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle

Preliminary estimation of the basic reproduction number of novel coronavirus

A data-driven analysis in the early phase of the outbreak

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

Novel Wuhan (2019-nCoV) coronavirus

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study

Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients

Liver injury in COVID-19: Management and challenges

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting

Hypokalemia and Clinical Implications in Patients with Coronavirus Disease 2019 (COVID-19)

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Diagnostic and prognostic value of very high serum lactate dehydrogenase in admitted medical patients

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study

COVID-19, ECMO, and lymphopenia: A word of caution